WAVE Life Sciences Stock (NASDAQ: WVE) stock price, news, charts, stock research, profile.
Open | $4.920 |
Close | $4.740 |
Volume / Avg. | 397.715K / 889.297K |
Day Range | 4.725 - 4.920 |
52 Wk Range | 3.150 - 7.670 |
Market Cap | $579.627M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 5.31% |
Days to Cover | 4.5 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of WAVE Life Sciences (NASDAQ: WVE) through any online brokerage.
Other companies in WAVE Life Sciences’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Phibro Animal Health (NASDAQ:PAHC).
The latest price target for WAVE Life Sciences (NASDAQ: WVE) was reported by Truist Securities on Monday, April 1, 2024. The analyst firm set a price target for 17.00 expecting WVE to rise to within 12 months (a possible 258.65% upside). 11 analyst firms have reported ratings in the last year.
The stock price for WAVE Life Sciences (NASDAQ: WVE) is $4.74 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for WAVE Life Sciences.
WAVE Life Sciences’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for WAVE Life Sciences.
WAVE Life Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.